SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
IrisWangYuSuzhou
Lv6
1890 积分
2023-10-27 加入
最近求助
最近应助
互助留言
2023 结直肠癌靶向治疗中国专家共
9天前
已完结
Resistance to antibody-drug conjugates in breast cancer: mechanisms and solutions
9天前
已完结
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project
13天前
已完结
A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy
21天前
已完结
乳腺癌HER2 检测指南(2023版)
22天前
已关闭
Prognostic value and morphological findings of overexpression of glypican-3 in hepatocellular carcinoma
28天前
已完结
Construction and evaluation of GPC3-targeted immunotoxins as a novel therapeutic modality for hepatocellular carcinoma
28天前
已完结
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial (LBA 5)
1个月前
已完结
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
1个月前
已完结
PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion
1个月前
已完结
没有进行任何应助
感谢
1个月前
标题不对
1个月前
感谢
1个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论